Klin Farmakol Farm. 2021;35(1):19-23

Importance of antiepileptic drugs interactions in routine clinical practice

Ivana Kacířová1, 2, Milan Grundmann1
1 Ústav klinické farmakologie, Lékařská fakulta, Ostravská univerzita, Ostrava
2 Oddělení klinické farmakologie, Ústav laboratorní medicíny, Fakultní nemocnice Ostrava

The propensity of drug-drug interactions in antiepileptic drugs is high. The outcome either may be beneficial, if the therapeutic potency of the drug is enhanced, or harmful if the interaction causes an increase in the adverse effects of the drug or if a reduction in efficacy occurs. It is difficult to predict the full extent of drug interactions because of the large interindividual variation between patients. Therapeutic drug monitoring has been used as a tool to optimize therapy regimens for individual patient with epilepsy.

Keywords: antiepileptic drugs, interaction, therapeutic drug monitoring.

Published: April 9, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kacířová I, Grundmann M. Importance of antiepileptic drugs interactions in routine clinical practice. Klin Farmakol Farm. 2021;35(1):19-23.
Download citation

References

  1. Patsalos PN, Spencer EP, Berry DJ. Therapeutic Drug Monitoring of Antiepileptic Drugs in Epilepsy: A 2018 Update. Ther Drug Monit. 2018 Oct; 40(5): 526-548. Go to original source... Go to PubMed...
  2. Verrotti A, Lattanzi S, Brigo F, Zaccara G. Pharmacodynamic interactions of antiepileptic drugs: From bench to clinical practice. Epilepsy Behav. 2020 Mar; 104(Pt A): 106939. Go to original source... Go to PubMed...
  3. Landmark CJ, Johannesse SI, Tomson T. Dosing strategies for antiepileptic drugs: from a standard dose for all to individualised treatment by implementation of therapeutic drug monitoring. Epileptic Disord. 2016 Dec 1; 18(4): 367-383. Go to original source... Go to PubMed...
  4. Koristkova B, Grundmann M, Brozmanova H, Kacirova I. Lamotrigine drug interactions in combination therapy and the influence of therapeutic drug monitoring on clinical outcomes in paediatric patients. Basic Clin Pharmacol Toxicol. 2019; 125: 26-33. Go to original source... Go to PubMed...
  5. Nigam SK. What do drug transporters really do? Nat Rev Drug Discov. 2015 January; 14(1): 29-44. Go to original source... Go to PubMed...
  6. Liu X. Transporter‑Mediated Drug‑Drug Interactions and Their Significance. Adv Exp Med Biol 2019; 1141: 241-291. Go to original source... Go to PubMed...
  7. Garg N, Joshi R, Medh, B.A. novel approach of targeting refractory epilepsy: Need of an hour. Brain Res Bull. 2020 Oct; 163: 14-20. Go to original source... Go to PubMed...
  8. Al‑Quteimat O, Laila A. Valproate Interaction With Carbapenems: Review and Recommendations. Hosp Pharm. 2020 Jun; 55(3): 181-187. Go to original source... Go to PubMed...
  9. Dreucean D, Beres K, McNierney‑Moore A, Gravino D. Use of meropenem to treat valproic acid overdose. Am J Emerg Med. 2019 Nov; 37(11): 2120.e5-2120.e7. Go to original source... Go to PubMed...
  10. Thomas C, Priano J, Smith TL. Meropenem as an antidote for intentional valproic acid overdose. Am J Emerg Med. 2020 Mar; 38(3): 690.e1-690.e2. Go to original source... Go to PubMed...
  11. Briguglio M, Hrelia S, Malaguti M, Serpe L, Canaparo R, Dell'Osso B, Galentino R, De Michele S, Dina CZ, Porta M, Banfi G. Food Bioactive Compounds and Their Interference in Drug Pharmacokinetic/Pharmacodynamic Profiles. Pharmaceutics. 2018 Dec 14; 10(4): 277. Go to original source... Go to PubMed...
  12. Fong S, Gao Q, Zuo Z. Interaction of Carbamazepine with Herbs, Dietary Supplements, and Food: A Systematic Review. Evid Based Complement Alternat Med. 2013; 2013: 898261. Go to original source... Go to PubMed...
  13. Nomani H, Moghadam AT, Emami SA, Mohammadpour AH, Johnston TP, Sahebkar A. Drug interactions of cola‑containing drinks. Clin Nutr. 2019 Dec; 38(6): 2545-2551. Go to original source... Go to PubMed...
  14. www.sukl.cz
  15. Kverneland M, Tauboll E, Molteberg E, Veierod MB, Selmer KK, Nakken KO, Iversen PO. Pharmacokinetic interaction between modified Atkins diet and antiepileptic drugs in adults with drug‑resistant epilepsy. Epilepsia. 2019; 60: 2235-2244. Go to original source... Go to PubMed...
  16. Czuczwar M, Kis J, Czuczwar P, Wielosz M, Turski W. Nicotine diminishes anticonvulsant activity of antiepileptic drugs in mice. Pol J Pharmacol. Sep-Oct 2003; 55(5): 799-802.
  17. Tomson T, Marson A, Boon P, Canevini MP, Covanis A, Gaily E, Kälviäinen R, Trinka E. Valproate in the treatment of epilepsy in girls and women of childbearing potential. Epilepsia 2015; 56(7): 1006-1019. Go to original source... Go to PubMed...
  18. Kacířová I, Grundmann M, Kořístková B, Brozmanová H. Development of a treatment of pregnant women suffering from epilepsy in the region of Ostrava between the years 1991 and 1996. Čes slov Farm 2010; 59(4): 172-178.
  19. Kacirova I, Grundmann M, Brozmanová H. Serum levels of lamotrigine during delivery in mothers and their infants. Epilepsy Res 2010; 91: 161-165. Go to original source... Go to PubMed...
  20. Kacirova I, Grundmann M, Brozmanova H. Serum levels of valproic acid during delivery in mothers and in umbilical cord - correlation with birth length and weight. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2015; 159(4): 569-575. Go to original source... Go to PubMed...
  21. Kacirova I, Grundmann M. Trend analysis of the utilization of antiepileptic drugs in pregnant women with epilepsy in Moravian‑Silesian region of the Czech Republic. Klin Farmakol Farm 2016; 30(2): 23-28.
  22. Kacirova I, Grundmann M, Brozmanova H. Concentrations of carbamazepine and carbamazepine-10,11-epoxide in maternal and umbilical cord blood at birth: Influence of co‑administration of valproic acid or enzyme‑inducing antiepileptic drugs. Epilepsy Res 2016; 122: 84-90. Go to original source... Go to PubMed...




Clinical Pharmacology and Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.